90 related articles for article (PubMed ID: 6392831)
1. Virulence, capsule size and lipid composition interrelation of Cryptococcus neoformans.
Upreti HB; Rawat DS; Das SK
Microbiologica; 1984 Oct; 7(4):371-4. PubMed ID: 6392831
[TBL] [Abstract][Full Text] [Related]
2. Lipid composition of Cryptococcus neoformans.
Rawat DS; Upreti HB; Das SK
Microbiologica; 1984 Oct; 7(4):299-307. PubMed ID: 6392829
[TBL] [Abstract][Full Text] [Related]
3. [Contributions to the strain-specific virulence of Cryptococcus neoformans. Animal experiments with two C. neoformans-strains isolated from bird manure. Preliminary report (author's transl)].
Staib F; Mishra SK
Zentralbl Bakteriol Orig A; 1975 Jan; 230(1):81-5. PubMed ID: 1101575
[TBL] [Abstract][Full Text] [Related]
4. [The defensive role of human pulmonary alveolar macrophages and polymorphonuclear leukocytes against a strongly or weakly virulent strains of Cryptococcus neoformans].
Tabeta H; Kohno N; Kamei K; Honda A; Unno H; Nagao K; Yamaguchi T; Miyaji M
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Sep; 29(9):1174-9. PubMed ID: 1753544
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the virulence of Cr. neoformans strains, of animal or telluric origin, against mice].
Gargani G
Boll Ist Sieroter Milan; 1977 Sep; 56(4):365-83. PubMed ID: 334195
[No Abstract] [Full Text] [Related]
6. Sec6-dependent sorting of fungal extracellular exosomes and laccase of Cryptococcus neoformans.
Panepinto J; Komperda K; Frases S; Park YD; Djordjevic JT; Casadevall A; Williamson PR
Mol Microbiol; 2009 Mar; 71(5):1165-76. PubMed ID: 19210702
[TBL] [Abstract][Full Text] [Related]
7. Cryptococcus neoformans capsule biosynthesis and regulation.
Janbon G
FEMS Yeast Res; 2004 Sep; 4(8):765-71. PubMed ID: 15450183
[TBL] [Abstract][Full Text] [Related]
8. Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence.
Moyrand F; Fontaine T; Janbon G
Mol Microbiol; 2007 May; 64(3):771-81. PubMed ID: 17462022
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the model pathogenic fungus Cryptococcus neoformans.
Idnurm A; Bahn YS; Nielsen K; Lin X; Fraser JA; Heitman J
Nat Rev Microbiol; 2005 Oct; 3(10):753-64. PubMed ID: 16132036
[TBL] [Abstract][Full Text] [Related]
10. Cryptococcus neoformans--pathogen and saprophyte.
Campbell CK; Mackenzie DW
Soc Appl Bacteriol Symp Ser; 1980; 9():249-58. PubMed ID: 7013081
[No Abstract] [Full Text] [Related]
11. The second STE12 homologue of Cryptococcus neoformans is MATa-specific and plays an important role in virulence.
Chang YC; Penoyer LA; Kwon-Chung KJ
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3258-63. PubMed ID: 11248066
[TBL] [Abstract][Full Text] [Related]
12. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis.
Mylonakis E; Moreno R; El Khoury JB; Idnurm A; Heitman J; Calderwood SB; Ausubel FM; Diener A
Infect Immun; 2005 Jul; 73(7):3842-50. PubMed ID: 15972469
[TBL] [Abstract][Full Text] [Related]
13. Capsule size of Cryptococcus neoformans: control and relationship to virulence.
Dykstra MA; Friedman L; Murphy JW
Infect Immun; 1977 Apr; 16(1):129-35. PubMed ID: 326665
[TBL] [Abstract][Full Text] [Related]
14. Role and mechanism of phosphatidylinositol-specific phospholipase C in survival and virulence of Cryptococcus neoformans.
Chayakulkeeree M; Sorrell TC; Siafakas AR; Wilson CF; Pantarat N; Gerik KJ; Boadle R; Djordjevic JT
Mol Microbiol; 2008 Aug; 69(4):809-26. PubMed ID: 18532984
[TBL] [Abstract][Full Text] [Related]
15. Cryptococcus neoformans: a sugar-coated killer with designer genes.
Perfect JR
FEMS Immunol Med Microbiol; 2005 Sep; 45(3):395-404. PubMed ID: 16055314
[TBL] [Abstract][Full Text] [Related]
16. [Cryptococcosis. A study of 9 strains of Cryptococcus neoformans isolated from immunodeficient patients].
Nobre G; Ramalho MO; Mendes E; Charrua MJ
Acta Med Port; 1990; 3(3):155-8. PubMed ID: 2220425
[TBL] [Abstract][Full Text] [Related]
17. [Phenotype characterization of environmental Cryptococcus neoformans isolates].
Huérfano S; Cepero MC; Castañeda E
Biomedica; 2003 Sep; 23(3):328-40. PubMed ID: 14582336
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcus neoformans capsule structure evolution in vitro and during murine infection.
Garcia-Hermoso D; Dromer F; Janbon G
Infect Immun; 2004 Jun; 72(6):3359-65. PubMed ID: 15155641
[TBL] [Abstract][Full Text] [Related]
19. Depletion of murine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans.
Mody CH; Chen GH; Jackson C; Curtis JL; Toews GB
J Lab Clin Med; 1993 Jun; 121(6):765-73. PubMed ID: 7685044
[TBL] [Abstract][Full Text] [Related]
20. Characterization of pathogenic constituents of Cryptococcus neoformans strains.
Kagaya K; Yamada T; Miyakawa Y; Fukazawa Y; Saito S
Microbiol Immunol; 1985; 29(6):517-32. PubMed ID: 3900645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
